Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hermann

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Expert Review of Neurotherapeutics|September 4, 2018
Diagnostic challenges in rapidly progressive dementiaInga Zerr, Peter Hermann
Nature Reviews. Neurology|May 4, 2022
Rapidly progressive dementias - aetiologies, diagnosis and managementPeter Hermann, Inga Zerr
Prion|May 12, 2024
Unmet needs of biochemical biomarkers for human prion diseasesPeter Hermann, Inga Zerr
Der Nervenarzt|March 20, 2024
[Clinical characteristics and diagnostics of human spongiform encephalopathies: an update]Peter Hermann, Stefan Goebel, Inga Zerr
Herz|May 25, 2005
[Dyspnea and normal systolic function]Gerd Hasenfuss, Hans-Peter Hermann, Burkert Pieske
Expert Opinion on Investigational Drugs|October 22, 2020
Genetic prion disease: opportunities for early therapeutic intervention with rigorous pre-symptomatic trialsPeter Hermann, Jan C Koch, Inga Zerr
Pediatric Hematology and Oncology|February 5, 2013
Long-term effects of chemotherapy on dental status of children cancer survivorsOrsolya Nemeth, Peter Hermann, Peter Kivovics, et al.
The Lancet. Neurology|January 24, 2026
Advances in biomarkers for diagnosis and prognosis of prion diseasesInga Zerr, Peter Hermann, Tze How Mok, et al.
Plos One|August 23, 2014
CSF biomarkers and neuropsychological profiles in patients with cerebral small-vessel diseasePeter Hermann, Carlos Romero, Christian Schmidt, et al.
The American Journal of Drug and Alcohol Abuse|January 24, 2012
Neurological abnormalities in opiate addicts with and without substitution therapyRobert Paur, Christine Wallner, Peter Hermann, et al.
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Expert Review of Neurotherapeutics|September 4, 2018
Diagnostic challenges in rapidly progressive dementiaInga Zerr, Peter Hermann
Nature Reviews. Neurology|May 4, 2022
Rapidly progressive dementias - aetiologies, diagnosis and managementPeter Hermann, Inga Zerr
Prion|May 12, 2024
Unmet needs of biochemical biomarkers for human prion diseasesPeter Hermann, Inga Zerr
Der Nervenarzt|March 20, 2024
[Clinical characteristics and diagnostics of human spongiform encephalopathies: an update]Peter Hermann, Stefan Goebel, Inga Zerr
Herz|May 25, 2005
[Dyspnea and normal systolic function]Gerd Hasenfuss, Hans-Peter Hermann, Burkert Pieske
Expert Opinion on Investigational Drugs|October 22, 2020
Genetic prion disease: opportunities for early therapeutic intervention with rigorous pre-symptomatic trialsPeter Hermann, Jan C Koch, Inga Zerr
Pediatric Hematology and Oncology|February 5, 2013
Long-term effects of chemotherapy on dental status of children cancer survivorsOrsolya Nemeth, Peter Hermann, Peter Kivovics, et al.
The Lancet. Neurology|January 24, 2026
Advances in biomarkers for diagnosis and prognosis of prion diseasesInga Zerr, Peter Hermann, Tze How Mok, et al.
Plos One|August 23, 2014
CSF biomarkers and neuropsychological profiles in patients with cerebral small-vessel diseasePeter Hermann, Carlos Romero, Christian Schmidt, et al.
The American Journal of Drug and Alcohol Abuse|January 24, 2012
Neurological abnormalities in opiate addicts with and without substitution therapyRobert Paur, Christine Wallner, Peter Hermann, et al.
Pageof 11